PSMA Protein Showing Its Mettle in the Battle Against Prostate Cancer

Despite the rapid advances that have been made in the detection and treatment of prostate cancer, it remains the second leading cause of cancer deaths among men worldwide. As such, we need to expand our understanding of the pathology of the disease and the related biomarkers.

In recent years, a unique protein known as prostate-specific membrane antigen (PSMA) has become one of the most exciting biomarkers for prostate cancer. PSMA is expressed in high concentrations in the prostate and is upregulated 100-1000-fold in prostate tumors. As a result, the role of PSMA in prostate cancer has been widely investigated and it is now recognized as a highly specific target for both diagnostic imaging and therapeutics in prostate cancer patients.

Read this white paper to learn more about the functions and tumor-promoting effects of PSMA in the prostate and discover how this biomarker is being used in the fight against prostate cancer.

Key points discussed:

• The function of PSMA and how it promotes prostate tumor growth
• The value of PSMA in prostate cancer imaging and diagnostics
•  The use of PSMA for targeted prostate cancer therapy